Valtrex Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

valtrex

glaxosmithkline nz limited - valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg;  ; valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg - film coated tablet - 500 mg - active: valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg   excipient: carnauba wax colloidal silicon dioxide crospovidone edible ink blue brilliant 5312 magnesium stearate microcrystalline cellulose opadry white ys1-18043 povidone purified water   active: valaciclovir hydrochloride 556mg equivalent to valaciclovir 500 mg excipient: carnauba wax colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry white ys1-18043 povidone purified water   - · valtrex is indicated for the treatment of herpes zoster (shingles) and the reduction of zoster - associated pain, which includes acute and post herpetic neuralgia, when given to immunocompetent patients in infection of less than 72 hours duration.

Zeffix Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

zeffix

glaxosmithkline nz limited - lamivudine 100mg;   - film coated tablet - 100 mg - active: lamivudine 100mg   excipient: magnesium stearate opadry butterscotch ys-1r-17307-a powdered cellulose sodium starch glycolate - zeffix is indicated for the treatment of adults and children aged 2 years and older with chronic hepatitis b and evidence of hepatitis b viruse (hbv) replication.

Zovirax Ophthalmic Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

zovirax ophthalmic

glaxosmithkline nz limited - aciclovir 3%{relative} - eye ointment - 3% w/w - active: aciclovir 3%{relative} excipient: white soft paraffin - treatment of herpes simplex keratitis.

BETNOVATE N Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

betnovate n

glaxo laboratories limited - betamethasone valerate neomycin sulfate - ointment - 0.1/0.5 %w/w

CEPOREX Granules for Oral Suspension 125 mg/5ml MG/5ml Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

ceporex granules for oral suspension 125 mg/5ml mg/5ml

glaxo laboratories limited - cefalexin - granules for oral suspension - 125 mg/5ml mg/5ml

CEPOREX Granules for Oral Suspension 250 mg/5 MG/5ml Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

ceporex granules for oral suspension 250 mg/5 mg/5ml

glaxo laboratories limited - cefalexin - granules for oral suspension - 250 mg/5 mg/5ml

BETNOVATE N 0.1/0.5 %w/w Ointment Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

betnovate n 0.1/0.5 %w/w ointment

glaxo laboratories limited - betamethasone valerate neomycin sulfate - ointment - 0.1/0.5 %w/w

CEPOREX 250 mg/5 MG/5ml Granules for Oral Suspension Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

ceporex 250 mg/5 mg/5ml granules for oral suspension

glaxo laboratories limited - cefalexin - granules for oral suspension - 250 mg/5 mg/5ml

CEPOREX 125 mg/5ml MG/5ml Granules for Oral Suspension Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

ceporex 125 mg/5ml mg/5ml granules for oral suspension

glaxo laboratories limited - cefalexin - granules for oral suspension - 125 mg/5ml mg/5ml

Imigran Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

imigran

glaxosmithkline nz limited - sumatriptan succinate 16.8 mg/ml;   - solution for injection - 6 mg/0.5ml - active: sumatriptan succinate 16.8 mg/ml   - imigran injection is indicated for the acute relief of migraine attacks with or without aura, and for the acute treatment of cluster headache.